title: XRN1 Is a Species-Specific Virus Restriction Factor in Yeasts.
abstract: In eukaryotes, the degradation of cellular mRNAs is accomplished by Xrn1 and the cytoplasmic exosome. Because viral RNAs often lack canonical caps or poly-A tails, they can also be vulnerable to degradation by these host exonucleases. Yeast lack sophisticated mechanisms of innate and adaptive immunity, but do use RNA degradation as an antiviral defense mechanism. One model is that the RNA of yeast viruses is subject to degradation simply as a side effect of the intrinsic exonuclease activity of proteins involved in RNA metabolism. Contrary to this model, we find a highly refined, species-specific relationship between Xrn1p and the "L-A" totiviruses of different Saccharomyces yeast species. We show that the gene XRN1 has evolved rapidly under positive natural selection in Saccharomyces yeast, resulting in high levels of Xrn1p protein sequence divergence from one yeast species to the next. We also show that these sequence differences translate to differential interactions with the L-A virus, where Xrn1p from S. cerevisiae is most efficient at controlling the L-A virus that chronically infects S. cerevisiae, and Xrn1p from S. kudriavzevii is most efficient at controlling the L-A-like virus that we have discovered within S. kudriavzevii. All Xrn1p orthologs are equivalent in their interaction with another virus-like parasite, the Ty1 retrotransposon. Thus, the activity of Xrn1p against totiviruses is not simply an incidental consequence of the enzymatic activity of Xrn1p, but rather Xrn1p co-evolves with totiviruses to maintain its potent antiviral activity and limit viral propagation in Saccharomyces yeasts. Consistent with this, we demonstrated that Xrn1p physically interacts with the Gag protein encoded by the L-A virus, suggesting a host-virus interaction that is more complicated than just Xrn1p-mediated nucleolytic digestion of viral RNAs.
authors.affiliation: BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, United States of America.|Section of Molecular Biosciences, University of Texas at Austin, Austin, Texas, United States of America.
authors.forename: Paul A
authors.initials: PA
authors.lastname: Rowley
authors.affiliation: Section of Molecular Biosciences, University of Texas at Austin, Austin, Texas, United States of America.
authors.forename: Brandon
authors.initials: B
authors.lastname: Ho
authors.affiliation: Section of Molecular Biosciences, University of Texas at Austin, Austin, Texas, United States of America.
authors.forename: Sarah
authors.initials: S
authors.lastname: Bushong
authors.affiliation: Section of Molecular Biosciences, University of Texas at Austin, Austin, Texas, United States of America.
authors.forename: Arlen
authors.initials: A
authors.lastname: Johnson
authors.affiliation: BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, United States of America.|Section of Molecular Biosciences, University of Texas at Austin, Austin, Texas, United States of America.
authors.forename: Sara L
authors.initials: SL
authors.lastname: Sawyer
mesh_terms: D015153:Blotting, Western; D005095:Exoribonucleases / Q000378:metabolism*; D006790:Host-Parasite Interactions / Q000502:physiology*; D047468:Immunoprecipitation; D016133:Polymerase Chain Reaction; D012367:RNA, Viral / Q000235:genetics; D012441:Saccharomyces cerevisiae / Q000378:metabolism* / Q000821:virology*; D029701:Saccharomyces cerevisiae Proteins / Q000378:metabolism*; D019197:Totivirus
chemical_list: D012367:RNA, Viral; D029701:Saccharomyces cerevisiae Proteins; D005095:Exoribonucleases; C068398:XRN1 protein, S cerevisiae